Page last updated: 2024-12-05

2-methoxybenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Methoxybenzoic acid, also known as o-anisic acid, is a white crystalline solid with a pleasant odor. It is a common organic compound used in various applications, including:

* **Synthesis:** 2-Methoxybenzoic acid is a key intermediate in the synthesis of other organic compounds, such as pharmaceuticals, agrochemicals, and dyes. It can be synthesized through various methods, including the methylation of salicylic acid.

* **Pharmacology:** 2-Methoxybenzoic acid exhibits biological activity and has been studied for its potential therapeutic effects, particularly in anti-inflammatory and analgesic applications.

* **Importance:** 2-Methoxybenzoic acid is an important building block in the chemical industry and is used as a precursor for various synthetic reactions. Its derivatives have found applications in diverse fields, including pharmaceuticals, agriculture, and materials science.

* **Research:** 2-Methoxybenzoic acid has been a subject of research due to its versatile chemical properties, its potential for medicinal applications, and its role in various synthetic processes. Researchers continue to explore its potential in diverse fields and to develop new and improved synthetic methods for its production.
'

O-methylsalicylic acid : A methoxybenzoic acid that is the methyl ether of salicylic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11370
CHEMBL ID192311
CHEBI ID421840
SCHEMBL ID3527
MeSH IDM0218421

Synonyms (70)

Synonym
kyselina 2-methoxybenzoova
4-10-00-00130 (beilstein handbook reference)
unii-49wa6z7gza
49wa6z7gza ,
nsc 3778
brn 0509929
kyselina 2-methoxybenzoova [czech]
einecs 209-447-8
2-anisic acid
ai3-20226
2-methoxybenzoic acid
nsc3778
o-methylsalicylic acid
o-methoxybenzoic acid
579-75-9
benzoic acid, 2-methoxy-
salicylic acid methyl ether
o-anisic acid
nsc-3778
TIMTEC1_004173
o-methoxy benzoic acid
inchi=1/c8h8o3/c1-11-7-5-3-2-4-6(7)8(9)10/h2-5h,1h3,(h,9,10
benzoic acid,2-methoxy
o-anisic acid, >=99%
2-methoxybenzoic acid, reagentplus(r), 99%
HMS1545N15
AC-3023
A0481
AKOS000103118
CHEMBL192311
FT-0657693
2-methoxy-benzoic acid
chebi:421840 ,
ortho-methoxybenzoic acid
A1729
2-methoxybenzoicacid
529-75-9
STL168881
FT-0612820
PS-5405
AQ-344/40173719
EPITOPE ID:124944
S6295
AB2883
SCHEMBL3527
methoxybenzoic acid, o-
fema no. 3943
2-methoxybenzoic acid [fhfi]
anisole carboxylic acid
methyl salicylic acid
1-carboxy-2-methoxybenzene
2-methoxy benzoic acid
DTXSID3060376
W-105423
F9995-1670
mfcd00002431
2-methoxybenzoic acid, vetec(tm) reagent grade, 98%
Z57127524
fema 3943
o-anisic acid, 8ci
CS-W019888
HY-N1393
SY003594
2-(methoxy-d3)benzoic acid
71F ,
Q2018545
EN300-18034
BBL036896
AMY293
o-anisic acid; 2-methoxybenzoic acid; nsc 3778; o-methylsalicylic acid; salicylic acid methyl ether; o-methoxybenzoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
non-steroidal anti-inflammatory drugAn anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
flavouring agentA food additive that is used to added improve the taste or odour of a food.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methoxybenzoic acidAny benzoic acid carrying one or more methoxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1339468Inhibition of wild type PI3K p110alpha/p85alpha niSH2 (unknown origin) expressed in baculovirus infected sf9 cells assessed as reduction in PIP3 formation at 100 uM using PIP2 as substrate after 45 mins by fluorescence polarization assay relative to contr2017Bioorganic & medicinal chemistry, 02-15, Volume: 25, Issue:4
Identification of allosteric binding sites for PI3Kα oncogenic mutant specific inhibitor design.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID1339469Inhibition of full length PI3Kalpha (unknown origin) assessed as reduction in PIP3 formation at 100 uM using PIP2 as substrate after 45 mins by fluorescence polarization assay relative to control2017Bioorganic & medicinal chemistry, 02-15, Volume: 25, Issue:4
Identification of allosteric binding sites for PI3Kα oncogenic mutant specific inhibitor design.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's5 (31.25)29.6817
2010's7 (43.75)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.27 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index56.01 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (40.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]